These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 2295043

  • 21. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO, Coussens D.
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract] [Full Text] [Related]

  • 22. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.
    Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC.
    J Urol; 1985 Mar; 133(3):403-7. PubMed ID: 4038749
    [Abstract] [Full Text] [Related]

  • 23. Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer.
    Iwasaki K, Obara W, Kato Y, Takata R, Tanji S, Fujioka T.
    Jpn J Clin Oncol; 2013 Feb; 43(2):193-9. PubMed ID: 23275643
    [Abstract] [Full Text] [Related]

  • 24. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 25. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
    Takenaka A, Gotoh A, Hara I, Gohji K, Ogawa T, Arakawa S, Matsumoto O, Kamidono S, Hamami G, Itani A.
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1909-15. PubMed ID: 2393308
    [Abstract] [Full Text] [Related]

  • 26. M-VAC or MVC for the treatment of advanced transitional cell carcinoma: metastatic, induction, and adjuvant.
    Soloway MS, Ishikawa S, Taylor T, Ezell G.
    J Surg Oncol Suppl; 1989 Sep; 1():40-5. PubMed ID: 2765094
    [Abstract] [Full Text] [Related]

  • 27. [Current status of adjuvant chemotherapy of invasive bladder cancer].
    Ozono S, Sasaki K, Watanabe S, Maruyama Y, Ohara S, Babaya K, Yamada K, Hirao Y, Okajima E.
    Hinyokika Kiyo; 1991 Dec; 37(12):1589-95. PubMed ID: 1785379
    [Abstract] [Full Text] [Related]

  • 28. [Neoadjuvant chemotherapy with MVC (methotrexate, vinblastine, cisplatin)in the treatment of infiltrating transitional carcinoma of the bladder].
    Campo B, Torelli T, Leidi GL, Corrada P, Bacchioni AM, Ordesi G, Zanitzer L.
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):237-42. PubMed ID: 2142807
    [Abstract] [Full Text] [Related]

  • 29. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder.
    Sternberg CN, Arena MG, Calabresi F, De Carli P, Platania A, Zeuli M, Giannarelli D, Cancrini A, Pansadoro V.
    Cancer; 1993 Sep 15; 72(6):1975-82. PubMed ID: 8364877
    [Abstract] [Full Text] [Related]

  • 30. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors.
    Scher HI, Yagoda A, Herr HW, Sternberg CN, Morse MJ, Sogani PC, Watson RC, Reuter V, Whitmore WF, Fair WR.
    J Urol; 1988 Mar 15; 139(3):475-7. PubMed ID: 3343729
    [Abstract] [Full Text] [Related]

  • 31. [M-VAC chemotherapy for patients with lymph node metastases and/or locally advanced bladder carcinoma].
    Igawa M, Ueki T, Ueda M, Okada K, Usui T, Ohnishi Y, Nakatsu H, Kume T, Kodama M, Masu C.
    Hinyokika Kiyo; 1989 Aug 15; 35(8):1323-7. PubMed ID: 2683648
    [Abstract] [Full Text] [Related]

  • 32. Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
    Pouessel D, Chevret S, Rolland F, Gravis G, Geoffrois L, Roubaud G, Terrisse S, Boyle H, Chevreau C, Dauba J, Moriceau G, Alexandre I, Deplanque G, Chapelle A, Vauleon E, Colau A, Audenet F, Grellety T, Culine S.
    Eur J Cancer; 2016 Feb 15; 54():69-74. PubMed ID: 26724422
    [Abstract] [Full Text] [Related]

  • 33. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
    Loehrer PJ, Einhorn LH, Elson PJ, Crawford ED, Kuebler P, Tannock I, Raghavan D, Stuart-Harris R, Sarosdy MF, Lowe BA.
    J Clin Oncol; 1992 Jul 15; 10(7):1066-73. PubMed ID: 1607913
    [Abstract] [Full Text] [Related]

  • 34. [Locally advanced or metastatic bladder carcinoma. Current aspects of therapy].
    Rübben H, Otto T.
    Urologe A; 2001 Nov 15; 40(6):464-7. PubMed ID: 11760352
    [Abstract] [Full Text] [Related]

  • 35. [Polychemotherapy in advanced bladder cancer. Practicality and clinical results].
    Klän R, Knispel H, Huland H.
    Urologe A; 1992 Jul 15; 31(4):247-50. PubMed ID: 1514213
    [Abstract] [Full Text] [Related]

  • 36. The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study.
    Meyers FJ, Palmer JM, Freiha FS, Harker EG, Shortliffe LD, Hannigan J, McWhirter K, Torti FM.
    J Urol; 1985 Dec 15; 134(6):1118-21. PubMed ID: 3903223
    [Abstract] [Full Text] [Related]

  • 37. Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.
    Sternberg CN, Yagoda A, Scher HI.
    Prog Clin Biol Res; 1988 Dec 15; 277():45-51. PubMed ID: 3054909
    [No Abstract] [Full Text] [Related]

  • 38. [Pelvic lymph node metastasis from bladder cancer markedly responsive to methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy followed by radiotherapy: a case report].
    Hatano K, Kawashima A, Arai Y, Inoue H, Miyagawa Y, Takaha N, Nishimura K, Miyake O, Okuyama A.
    Hinyokika Kiyo; 2006 Oct 15; 52(10):801-3. PubMed ID: 17131872
    [Abstract] [Full Text] [Related]

  • 39. Advanced small cell carcinoma of the bladder. Successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy.
    Oesterling JE, Brendler CB, Burgers JK, Marshall FF, Epstein JI.
    Cancer; 1990 May 01; 65(9):1928-36. PubMed ID: 2164873
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.